In other countries
The same active substances on other registers, the same brand first.
- Riopan Chewable Tablets 480MGCanada · 480 MG · Tablet · Wyeth-Ayerst Canada INC.Same brand
- Riopan Sus 480MG/5MLCanada · 480 MG / 5 ML · Suspension · Whitehall-Robins INC.Same brand
- Riopan Suspension 480MG/5MLCanada · 480 MG / 5 ML · Suspension · Wyeth-Ayerst Canada INC.Same brand
- RiopanItaly · Sospensione orale · Doc Generici SRLSame brand
- Riopan®Serbia · 800mg/10mL · oralna suspenzija · Takeda DOOSame brand
- Riopan®Serbia · 1600mg/10mL · oralna suspenzija · Takeda DOOSame brand
- GadralItaly · Sospensione orale · Neopharmed Gentili S.P.A.Same form
- Magaldrato MylanItaly · Sospensione orale · Mylan S.P.A.Same form
- Acicone 540MG-5ML SuspSaudi Arabia · Medical Union Pharmaceuticals CoSame form
- BEMOLAN 2000 mg GEL ORALSpain · 2000 mg · gel oral · Takeda Farmaceutica Espana S.A.Same substance
- BEMOLAN 800 mg GEL ORALSpain · 800 mg · gel oral · Takeda Farmaceutica Espana S.A.Same substance
- MAGION 450 mg COMPRIMIDOS MASTICABLESSpain · 450 mg · comprimido · Gentec S.A.Same substance
- Acicone 720 MG Chewable TabSaudi Arabia · Medical Union Pharmaceuticals CoSame substance
- Antacid Jedco 480MG Chewable TabletsSaudi Arabia · Jedco International PharmaceuticalSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Magaldrate
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 11 Sept 2017
- Registration
- 106390277
- Marketing authorisation holder
- Takeda Pharma Ltda.
- Procedure
- Registered



